Determination of Tamoxifen and its main metabolites in plasma samples from breast cancer patients by micellar liquid chromatography
Impact
Scholar |
Other documents of the author: Vives-Peris, Vicente; Ochoa Aranda, Enrique; Bose, Devasish; Esteve-Romero, Josep
Metadata
Show full item recordcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/7013
comunitat-uji-handle3:10234/8638
comunitat-uji-handle4:
INVESTIGACIONThis resource is restricted
http://www.sciencedirect.com/science/article/pii/S0039914014006614 |
Metadata
Title
Determination of Tamoxifen and its main metabolites in plasma samples from breast cancer patients by micellar liquid chromatographyDate
2015-01Publisher
ElsevierBibliographic citation
PERIS-VICENTE, Juan, et al. Determination of tamoxifen and its main metabolites in plasma samples from breast cancer patients by micellar liquid chromatography. Talanta, 2015, vol. 131, p. 535-540.Type
info:eu-repo/semantics/articlePublisher version
http://www.sciencedirect.com/science/article/pii/S0039914014006614Version
info:eu-repo/semantics/publishedVersionSubject
Abstract
A method was developed for the analysis of tamoxifen and its main derivatives (4-hydroxytamoxifen, N–desmethyl-tamoxifen, tamoxifen-N-oxide and endoxifen) in human plasma, using micellar liquid chromatography coupled ... [+]
A method was developed for the analysis of tamoxifen and its main derivatives (4-hydroxytamoxifen, N–desmethyl-tamoxifen, tamoxifen-N-oxide and endoxifen) in human plasma, using micellar liquid chromatography coupled with fluorescence detection. Analytes were off-line derivatized by sample UV-irradiation for 20 min to form the photocycled fluorescent derivatives. Then samples were diluted, filtered and directly injected, thus avoiding extraction steps. The analytes were resolved using a mobile phase containing 0.08 M SDS-4.5% butanol at pH 3 running at 1.5 mL/min through a C18 column at 40 °C, without interferences from endogenous compounds in plasma. Excitation and emission wavelengths were 260 and 380 nm, respectively. The chromatographic analysis time was less than 40 min. The analytical methodology was validated following the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines in terms of: selectivity, linear range (0.3–15 μg/mL), linearity (r2>0.999), sensitivity (LOD, 65–80 ng/mL; LOQ, 165–200 ng/mL), intra- and interday accuracy (−12.2–11.5%) and precision (<9.2%) and robustness (<6.3%). The method was used to quantify the tamoxifen and tamoxifen derivatives in several breast cancer patients from a local hospital, in order to study the correlation between the genotype of the patient and the ability to metabolize tamoxifen. [-]
Is part of
Talanta Volume 131, January 2015Rights
Copyright © 2014 Elsevier B.V. All rights reserved.
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
This item appears in the folowing collection(s)
- QFA_Articles [812]